このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

睡眠脳波、術中脳波と術後認知機能障害の関係 (SOMEDYSPO)

2026年9月17日 更新者:Assistance Publique - Hôpitaux de Paris

The challenge of new recommendations and better adapted practices is pushing to operate patients who are getting older and more fragile. In this context, there is an inevitable increase in the risks associated with care and in particular perioperative neurological complications, of which postoperative cognitive dysfunction (POCD) is the most common.

The interest of perioperative cerebral monitoring and in particular electroencephalography (EEG) to reduce neurological and cognitive damage in surgery has been the subject of abundant research and corresponds to a crucial issue.

From the literature and preliminary results obtained in our clinical research unit, it appears that there is also a relationship between certain characteristics of the peroperative EEG (signal strength and burst suppression) and the occurrence of postoperative cognitive dysfunction (PCOD).

In this context, quantitative analysis of the preoperative sleep EEG and the EEG obtained during general anesthesia could allow the identification of a simple to use biomarker of susceptibility or fragility. To our knowledge, there is no preoperative evaluation strategy using EEG analysis to detect a predisposition to POCD.

The main goal of this observational clinical study is to extend the traditional use of per-operative EEG with pre-operative and post-operative sleep EEG for the detection and prediction of early post-operative cognitive dysfunction.

調査の概要

詳細な説明

The interest of perioperative brain monitoring to reduce neurological and cognitive damage in surgery has been the subject of much research and corresponds to a crucial issue.

The notion of quantitative EEG covers all the electrical signal processing techniques (fast Fourier transformation, evoked potentials, EEG mapping, etc.) made possible through the digitization of EEG data and the development of software to process these signals. In this context, EEG-derived indices have been set up to monitor hypnosis during general anesthesia. Between 0 (deep hypnosis) and 100 (awakening), the Bispectral Index (BIS) integrates in its calculation the percentage of fast waves, the degree of wave synchronization and the periods of EEG suppression (or "Burst suppression") and allows an adaptation of the dosage of anesthetic products according to its value.

Avoiding too deep anesthesia through neuro-monitoring could help to reduce postoperative delirium by reducing the burst suppression pattern.

Pre-operative cognitive status assessment :

The investigators observe a great delay in the means implemented to have an objective evaluation of cognitive disorders in preoperative care.

One of the pitfalls of our anesthetist specialty is the lack of continuity of medical care in the perioperative period.

The geriatric evaluation including a MMSE (mental mini state examination) and a MoCA (Montreal cognitive assessment) is performed only occasionally.

Interest of the resting pre-operative EEG :

Sleep EEG analysis is already used in cognitive studies. Slow Wave Activity (SWA) is a parameter known to be inversely correlated with chronological age and lowered more significantly in the context of cognitive dysfunction.

The power of spindles or sleep spindles and particularly fast spindles have been shown to be potentially predictive of poor cognitive development in patients already showing symptoms (Mild Cognitive Impairment).

It is likely that per operative susceptibility to Burst suppression and the appearance of postoperative cognitive dysfunction are linked to a set of per operative factors (anesthesia, surgery, inflammation, pain...) but also preoperative factors (cognitive state, physiological age and cerebral fragility...).

The investigators hypothesize that there is an association between preoperative resting EEG abnormalities and the risk of postoperative cognitive dysfunction.

The goal of this observational clinical study is to assess the fragility of a patient under general anesthesia and based on the perioperative quantitative analysis EEG. Thus, this project should help specialists in perioperative medicine to identify patients at risk of cognitive dysfunction and could lead to proposing strategies for its prevention.

Measures are based on neuro-psychological tests (Montreal cognitive assesment -MoCA) and EEG signal and subfrequency power spectral densities including alpha band as well as the amount of Propofol, each measured for EEG periods where SEF 95 = 8-13Hz.

Analysis includes the characteristics of the preoperative sleep EEG (SWA, fast spindles).

Experimental design: This is a single-center, observational prospective study.

Population concerned :

Patients eligible for interventional neuroradiology or surgery performed under General Anesthesia are selected to participate in this prospective, observational, single-center, routine care study. Patients will be included if they received, for a non-urgent scheduled procedure.

Patients over 18 years of age are eligible to participate in this protocol. During the anesthesia consultation, they will be given a hand-delivered letter of information on the objectives and the course of the study. Their non-opposition to participating in this study will be collected at the latest during the pre-anesthetic visit, on the eve of the operation after a period of reflection.

The protocol will start the day before the intervention. The interventions will be performed under general anaesthesia. The protocol does not interact with the care procedure. All the measures are obtained non-invasively.

The day before the procedure: performance of a sleep EEG (DREEM®) and a MoCA test. On the day of the procedure, monitoring of the depth of anesthesia using the quantitative EEG (Sedline Masimo®) ensures continuous recording of intraoperative EEG data. Postoperatively the same investigator performs MoCA at Day1, Day2 and Day5. A sleep EEG (DREEM®) is performed at Day2 and Day5 if the patient is still hospitalized.

During their general anesthesia, all patients' routine monitoring will consist in collecting the following parameters: electrocardiogram, pulsated oxygen saturation, endtidal CO2, respiratory rate, tidal volume and neuromuscular function.

For all patients whatever the comorbidities, anesthesia induction will be performed using a target-controlled infusion (Orchestra® Base Primea - Fresenius Kabi France).

No additional additional examination will be performed. The anesthetic strategy is decided by the anesthetist in charge of the procedure.

The doctor in charge of the study collecting the data does not interfere at any time in the management of the patient. The measurements cannot influence the prescribing physician since at this stage the data are not yet analysed and available.

Number of selected subjects: Assuming an incidence of DCPO of 30%, with power at 80% and alpha risk at 5%, it is necessary to include 100 patients to demonstrate an area under the ROC curve of 80% with a confidence interval width of 0.1

Statistics:

Continuous data will be expressed in median [interquartile] and qualitative data in n (%). Categorical variables will be compared by Mann-Whitney test and continuous variables by Wilcoxon test.

In this study, the primary endpoint was the occurrence of post-operative cognitive dysfunction, defined as a decrease in MoCA score of more than 4 points between preoperative and postoperative periods (worst value of the score measured at D1, D2 and D5). The main exposure is the quantitative score obtained from the analysis of the pre-operative sleep EEG.

The ability of the various parameters of interest of the preoperative sleep EEG to predict the occurrence of DCPO will be estimated by constructing an ROC curve. The area of these ROC curves will be measured and the corresponding 95% confidence interval estimated. The areas under the ROC curve of the different parameters will be compared by DeLong test. A uni- and then multivariate analysis will be performed to identify the clinical parameters associated with the occurrence of a DCPO. The possible added value of the sleep EEG parameters on the clinical parameters will be evaluated by reclassification techniques.

The statistical analysis will be carried out using the statistical analysis software "R" (The R Foundation, Vienna, Austria)

研究の種類

観察的

入学 (実際)

66

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

      • Paris、フランス、75010
        • AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年歳以上 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

サンプリング方法

確率サンプル

調査対象母集団

Patients eligible for a non-emergency scheduled interventional neuroradiology procedure or surgery performed under general anesthesia.

説明

Inclusion Criteria:

  • Major patients (≥ 18 years )
  • Eligible for an interventional radiology procedure or surgery under general anesthesia
  • Patients informed and having expressed their non-opposition to participation in this research

Exclusion Criteria:

  • Patients under 18 years old
  • Severe pre-existing cognitive impairment (preoperative mini-mental state examination (MMSE) < 24)
  • Patient opposed to protocol participation
  • Pregnant woman
  • Patient under judicial protection
  • Patient without affiliation to a social security scheme
  • Emergency procedure

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
Patients undergoing general anesthesia

Patients eligible for interventional neuroradiology or surgery performed under general anesthesia. Patients will be included if they are admitted for a non-emergency scheduled procedure.

Sleep EEG recording using a Dreem® headband (Rythm, Paris, France), an EEG recording device adapted to sleep conditions and completely non-invasive

Neuropsychological assessment using the The Montreal Cognitive Assessment (MoCA) questionnaire to detect postoperative cognitive dysfunction

Intraoperative brain function monitoring using a Sedline® module (Masimo corporation) to evaluate the state of the brain under anesthesia

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Early postoperative cognitive dysfunction
時間枠:Change between day -1 and day 5

Score obtained following evaluation of the patient's cognitive function using the Montreal Cognitive Assessment questionnaire MoCA (0-30; higher score indicates better performance)

Change between day -1 and day 5

二次結果の測定

結果測定
メジャーの説明
時間枠
Burst suppression duration
時間枠:Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

For all patients the values of Burst Suppression (in % of time) will be collected from frontal electrodes montage (Fp1, Fp2, F7, F8) during the total anesthesia period (induction and hypnotic periods)

Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)
Variations in alpha power on sleep EEG
時間枠:Change between day -1 and day 5

Variations in alpha power (in Decibel, Db) on the pre-operative and post-operative sleep EEG

Change between day -1 and day 5
Spindle amplitude on sleep EEG
時間枠:Change between day -1 and day 5

Spindle amplitude (in Decibel, Db) on preoperative and postoperative sleep EEG

Change between day -1 and day 5
Spindle frequency on sleep EEG
時間枠:Change between day -1 and day 5

Spindle frequency (in Hertz, Hz) on preoperative and postoperative sleep EEG

Change between day -1 and day 5

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • スタディディレクター:Joaquim MATEO, MD、Assistance Publique - Hôpitaux de Paris
  • 主任研究者:Fabrice VALLEE, MD、Assistance Publique - Hôpitaux de Paris

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2020年7月15日

一次修了 (実際)

2022年2月21日

研究の完了 (実際)

2022年2月21日

試験登録日

最初に提出

2020年6月23日

QC基準を満たした最初の提出物

2020年7月17日

最初の投稿 (実際)

2020年7月22日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月22日

QC基準を満たした最後の更新が送信されました

2026年9月17日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する